Literature DB >> 30517103

Development of a PCR algorithm to detect and characterize Neisseria meningitidis carriage isolates in the African meningitis belt.

Kanny Diallo1,2, Mamadou D Coulibaly1, Lisa S Rebbetts2, Odile B Harrison2, Jay Lucidarme3, Kadidja Gamougam4, Yenenesh K Tekletsion5, Akalifa Bugri6, Aliou Toure1, Bassira Issaka7, Marietou Dieng8, Caroline Trotter9, Jean-Marc Collard7, Samba O Sow1, Xin Wang10, Leonard W Mayer10, Ray Borrow3, Brian M Greenwood11, Martin C J Maiden2, Olivier Manigart11.   

Abstract

Improved methods for the detection and characterization of carried Neisseria meningitidis isolates are needed. We evaluated a multiplex PCR algorithm for the detection of a variety of carriage strains in the meningitis belt. To further improve the sensitivity and specificity of the existing PCR assays, primers for gel-based PCR assays (sodC, H, Z) and primers/probe for real-time quantitative PCR (qPCR) assays (porA, cnl, sodC, H, E, Z) were modified or created using Primer Express software. Optimized multiplex PCR assays were tested on 247 well-characterised carriage isolates from six countries of the African meningitis belt. The PCR algorithm developed enabled the detection of N. meningitidis species using gel-based and real-time multiplex PCR targeting porA, sodC, cnl and characterization of capsule genes through sequential multiplex PCR assays for genogroups (A, W, X, then B, C, Y and finally H, E and Z). Targeting both porA and sodC genes together allowed the detection of meningococci with a sensitivity of 96% and 89% and a specificity of 78% and 67%, for qPCR and gel-based PCR respectively. The sensitivity and specificity ranges for capsular genogrouping of N. meningitidis are 67% - 100% and 98%-100% respectively for gel-based PCR and 90%-100% and 99%-100% for qPCR. We developed a PCR algorithm that allows simple, rapid and systematic detection and characterisation of most major and minor N. meningitidis capsular groups, including uncommon capsular groups (H, E, Z).

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30517103      PMCID: PMC6281270          DOI: 10.1371/journal.pone.0206453

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

Neisseria meningitidis has been responsible for numerous outbreaks of septicaemia and meningitis in countries of the African Sahel and sub-Sahel, a region known as the “African meningitis belt”[1]. The devastating nature of this disease, which predominately affects children and young adults, makes its control an international health priority. N. meningitidis is a common commensal bacterium capable of harmlessly colonizing the upper respiratory tract in a dynamic process referred to as “carriage” [2]. Mucosal carriage is a necessary prerequisite for meningococcal disease. Carriage of N. meningitidis causes disease when it breaches the host epithelial barriers and invades the bloodstream or penetrates the subarachnoidal cavity and infects the meninges [3]. N. meningitidis are classified into 12 serogroups (A, B, C, E, H, I, K, L, W, X, Y and Z), based on the structure and chemical composition of their capsular polysaccharide [4]. The serogroups associated with disease in the African meningitis belt are A, W, X, Y and C. With serogroup A epidemics being eliminated following the introduction of the serogroup A conjugate vaccine MenAfriVac[5-7], non-A meningococcal serogroups become the major cause of meningococcal disease in sub Sahelian Africa. Recently, large serogroup C epidemics occurred in Niger and Nigeria, [8] demonstrating the epidemic potential of non- serogroup A meningococci. Timely control and prevention of the epidemics have been a challenge due to vaccine shortages, which has resulted in tremendous pressure on hospital facilities and public health authorities. Serogroup B, a common cause of meningococcal disease in many high-income countries [9], is rarely detected in the meningitis belt. Serogroups E, I, H, K, L, Z are less commonly identified in invasive disease. Queries on the more than 38,633 records on PubMLST.org/neisseria website have demonstrated that serogroups E and Z are found both in invasive and carriage specimens, serogroups K, L, H are only found in carriage samples but very rarely, and serogroup I was not found at the time of writing. Furthermore, previous carriage studies in Europe have identified a high proportion of N. meningitidis isolates, among which, up to 30–45% did not express their capsule genes [10] and 16–20% lacked regions A, B and C of the capsular polysaccharide synthesis (cps) genes, known as a capsule null (cnl) genotype [11]. Several meningococcal cross-sectional carriage studies have been conducted in the African meningitis belt in recent years, including surveys in Burkina Faso [12, 13], and in seven other countries (Chad, Ethiopia, Ghana, Mali, Niger, Nigeria and Senegal) as part of the MenAfriCar project [14, 15]. Conventional microbiological methods have been used in these studies to detect and characterise meningococci, but these methods are time consuming, expensive and susceptible to errors. Consequently, many African laboratories have been increasingly adopting molecular biology tools to detect and characterise N. meningitidis and its capsular genotypes as they are more sensitive, specific, and less time consuming than bacteriological methods. DNA-based methods such as Polymerase Chain Reaction (PCR) have greatly improved laboratory diagnosis [16]; many studies have developed reliable PCR assays for the detection of N. meningitidis [17-19] and characterization of its capsular genogroup using specific genes. However, most studies have focused on the common disease serogroups, A, B, C, W, X and Y [20-23]. Fewer studies have investigated PCR for the detection of cnl or serogroups E, H, and Z which are mostly found in carriage [20, 24]. Some research groups have developed gel-based PCR assays for the detection and genogrouping of N. meningitidis whereas others have used real-time quantitative PCR (qPCR) protocols. The choice of one technique over another is often dictated by budgetary considerations, as qPCR is more expensive but less subject to contamination. Evaluation of the impact of meningococcal conjugate vaccines requires sensitive and specific PCR assays that cover all serogroups to accurately and thoroughly assess the epidemiology of N. meningitidis carriage and disease, including the potential emergence of less common groups through strain replacement and/or capsule switching [25]. The present study was conducted within the MenAfriCar project, which collected pharyngeal swabs from over 60,000 subjects in seven countries within the African meningitis belt [15]. Our objectives were to improve N. meningitidis carriage assessment by developing and optimising a simple, accurate and standardised multiplex PCR algorithm for the detection of N. meningitidis species and its capsular genogroups including: (i) the most prevalent genogroups A, B, C, X, Y and W (ii) carriage-associated genogroups such as E, H, and Z; and (iii) unencapsulated capsule null meningococci. Both traditional gel-based PCR and qPCR that can be adapted to African laboratories were validated using carriage isolates collected as part of MenAfriCar studies.

Material and methods

Literature search for available primers/probes

A literature search was undertaken to identify PCR methods with primers and probes published on N. meningitidis detection and characterization. The NCBI PubMed database was used with search terms “Neisseria meningitidis” and “PCR” (date of access: November 2011). The different techniques and detection algorithms were evaluated in order to define the most appropriate ones for our context. A focus was placed on summarising the best gel-based and qPCR assays already existing for detection and characterization of meningococci.

In silico specificity screen—Evaluation of selected primers and probes

A total of 112 primers and 16 probes reported in the literature were chosen for further analysis. Firstly, nucleotide mismatches were identified through the comparison with consensus sequences derived from target genes obtained from the pubMLST.org/neisseria website (accessed on September 2012). Primer and probe sequences were compared to all available allelic variants of the target genes to determine whether they were conserved in the majority of alleles available at that time. Technical checks on all primers and probes were then undertaken using the Primer Express software design guidelines (Applied Biosystem International (ABI), Villon sur Yvette, France): melting point temperatures (Tm) and potential secondary structures were assessed with optimal Tm varying between 58–60°C and 68–70°C for primers and probes respectively. Finally, nucleotide BLAST searches were undertaken using the NCBI BLAST tool to identify possible cross-reactions with other bacteria [26]. Primers and probes with more than 3 base pair (bp) differences compared to the consensus sequences were not used. Secondary structures or self-dimers were minimised, to avoid their potential detrimental effect on the efficiency of the reaction, but their presence was not a systematic criterion for rejection. Sequences were retained if they displayed 100% coverage according to the NCBI BLAST tool. When the result of these evaluations was unsatisfactory, new primers and/or probes were created.

Positive controls

Positive controls consisted of purified DNA from genogroups: A (isolate name: Z2491); W (A22); X (860060); Y (71/94); B (EG329, BZ198); C (L93/4286); Z (0084/93); E (297–0); H (H/ASH/87); and capsule null (0083/93) [27] as well as two genogroup E isolates (M07746, M22445). Reference strains for genogroups A and X, were purchased from the American Type Culture Collection (ATCC). Another confirmed capsule null isolate from the first Malian MenAfriCar cross-sectional study (sample 01-010664-XS1) (18) was used as a cnl positive control.

Carriage isolates

N. meningitidis isolates were collected during the first MenAfriCar cross-sectional studies as previously described [15]. Briefly, pharyngeal swabs were obtained from participants in the rural and urban sites of six centres in Chad, Ethiopia, Ghana, Mali, Niger and Senegal. Suspected N. meningitidis were subjected to oxidase test, Gram stain, biochemical tests and sero-agglutination [28]. Boiled cell suspensions to release high concentration of DNA were prepared in each center as part of the MenAfriCar routine protocol from bacteria grown overnight on blood agar plates [15]. Extracted DNA samples from all oxidase positive bacteria were also sent to the University of Oxford [14] for molecular characterization. A subset of characterized samples was chosen to constitute a representative panel of the most prevalent N. meningitidis genogroups as well as non N. meningitidis from each country. Next, the selected boiled cell suspension extracted DNA samples were sent to the Center for Vaccine Development in Mali (CVD-Mali) where PCR validation was conducted. A total of 247 extracted DNA samples were received, with 42, 38, 18, 46, 44 and 59 samples from Chad, Ethiopia, Ghana, Niger, Mali and Senegal, respectively.

Characterisation of N. meningitidis at the University of Oxford, UK

Neisseria species were analysed using the rplF assay [29]. All samples were also tested with a capsule null (cnl) sequencing assay [11] or sequencing of a fragment of the ctrA gene allowing the characterisation of genogroup A, E, K, L, X and Z. Samples that were positive for N. meningitidis and negative for cnl were tested by a qPCR multiplex assay to determine genogroups A, B, C, W, X and Y [23]. These results were considered as the reference or gold standard for this study since the assays described above were already validated and published.

Novel gel-based PCR assay design and optimization in Bamako, Mali

New primers were designed for sodC, genogroup Z, and H using the online tools Primer 3 and Primer quest (Table 1)[30, 31]. A ready-to-load Master Mix (rlMMx) from Solis Biodyne, stable at room temperature and therefore very convenient for transport and testing in Africa, was employed. rlMMx with different concentrations of MgCl2 were tested to find the optimal concentration for the assay. Thermal cycling conditions were the same for all tests: 1 cycle of 3 minutes (min) at 95°C; 35 cycles of 30 seconds (s) at 95°C; 30 s at 55°C; 30 s at 72°C. This was followed by 1 cycle of 10 min at 72°C and a final conservation step at 4°C.
Table 1

Primer sequences for gel-based PCR.

GenePrimer nameSequenceStart/endSizeReference
porAporA 2F GCG GTT TTG CCG GGA ACT AT755–1017251Bennett, DE, 2006
porA 15RAGT GGC GGC AAT TTC GGT CGT ACT
galE-cnl-texGH26R (cnl aF) GGT CGT CTG AAA GCT TGC CTT GCT C250–226432Claus, H, 2002
HC344 (cnl aR) GGA TTG GAC GAG CGA GAC72–55
sodCsodC-F2GCG GTT AGT GCA GTA TGT TCA G113–641530Present study
sodC-R2TAA TCA CGC CAC ATG CCA TA
mynB/csaB98–28 (AF)CGC AAT AGG TGT ATA TAT TCT TCC270–664395Taha, MK, 2000
98–29 (AR)CGT AAT AGT TTC GTA TGC CTT CTT
siaD (csw)98–32 (W135F)CAG AAA GTG AGG GAT TTC CAT A911–1030120Taha, MK, 2000
98–33 (W135R)CAC AAC CAT TTT CAT TAT AGT TAC TGT
Xcba (csxA)X-10 (F)ACA GCC CAT AAA ACA CCC GTA TCA TC142–343202Yaro, S, 2012
X-11 (R)GTG ATT GGA ATC TTC CAA TAT CGG T
siaD (csb)98–20 (BF)GCA TGC TGG AGG AAT AAG CAT TAA645–1099455Taha, MK, 2000
98–19 (BR)GGA TCA TTT CAG TGT TTT CCA CCA
siaD (csc)98–17 (CF)TCA AAT GAG TTT GCG AAT AGA AGG T789–1054266Taha, MK, 2000
98–18 (CR)CAA TCA CGA TTT GCC CAA TTG AC
siaD (csy)98–34 (YF)CTC AAA GCG AAG GCT TTG GTT A911–1030120Taha, MK, 2000
98–35 (YR)CTG AAG CGT TTT CAT TAT AAT TGC TAA
cshCcshC-F1GTG CCG ATA TTG CCT CAG AT2378–2533156Present study
cshC-R1CTT CGG ATG GGA ACT TGA AA
cap29EH39429 (29E aF) TTG GCG GTT GAA ACC TTA C22–715694Zhu, H, 2011
39430 (29E aR) GCG TAT CAT GCT CCA TTA CCA
cszCcszC-Fwd (ZF)AGG TTC ATC TGC TGG GAT TAC GCT3506–3806301Present study
cszC-Rev (ZR)AAG CGA TTA ATG GCC TGT TGC TGG

Sequences, positions and amplicons size of each primer pair used in the 4 multiplexes. In bold are base pairs that showed a mismatch with at least one of the alleles present in pubMLST, but not with the majority of them.

Sequences, positions and amplicons size of each primer pair used in the 4 multiplexes. In bold are base pairs that showed a mismatch with at least one of the alleles present in pubMLST, but not with the majority of them.

Novel quantitative real-time PCR (qPCR) assay design and optimization in Bamako, Mali

Although our assay was developed to determine whether a specimen is positive or negative for meningococci and their genogroups, we keep the term “qPCR” to comply with the MIQE guidelines [32]. Quantification of meningococci would not add any information in our context since we were working with DNA samples extracted from bacterial culture. Primers and probes were designed for the N. meningitidis species-specific gene porA and for the non-species-specific cnl, and a modified species-specific sodC probe was designed based on a previously published method [18]. Genogroups were determined using the 2nd (A, W, X) and 3rd (B, C, Y) qPCR multiplexes developed by Wang et al. [23]. Primers and probes for these genogroups were kindly provided by the Centers for Disease Control and Prevention (CDC). Primers and probes were also designed for genogroups E, H, and Z using the Primer Express software from ABI. Minor Groove Binding (MGB) hydrolysis probes were designed, as opposed to Black Hole Quencher (BHQ) hydrolysis probes which are more difficult to manufacture. The sodC probe was modified in Primer Express to make it 12 base pairs shorter and accommodate an MGB quencher (Table 2). All primers/probe were tested at the following concentrations in a 25 μl solution: 900nM/250nM; 600nM/200nM; 300nM/100nM and 100nM/50nM respectively. Optimal concentrations in a TaqMan Gene Expression MasterMix (reference: 4369016 from ABI) were identified for each primers/probe set and used subsequently in the different assays. Cycling conditions were similar for all tests: 1 cycle of 2 min at 50°C, 1 cycle of 10 min at 95°C followed by 50 cycles of 15 s at 95°C and 1 min at 60°C. The ABI 7500 fast cycler was used to perform the reaction and the results analysed using the 7500 Fast software (see dx.doi.org/10.17504/protocols.io.rjsd4ne for detailed information).
Table 2

Primer and probe sequences for qPCR.

GenePrimer/Probe nameSequenceStart/endConcentration (nM)Reference
porAporA_fwd_1GCC GGC GTT GAT TAT GAT TT1126–1145600Present study
porA_rev_1AGT TGC CGA TGC CGG TAT T1210–1192600
porA_Pb_1 FAM (MGB)CTT CCG CCA TCG TGT C1157–1172200
sodCNm sodC FWd 351GCA CAC TTA GGT GAT TTA CCT GCA T446–470600Dolan, T,2011
Nm sodC Rev 478CCA CCC GTG TGG ATC ATA ATA GA551–573600
sodC Pb387 NED (MGB)CAT GAT GGC ACA GCA A482–497100Present study
galE/cnl/texcnl_fwd_2GAA TTG CAT AGG TTA TCC AAA ATC AC110–85900Present study
cnl_fwd_2bGAG TTG CAC AGA TTA TCC AGA ATC AC110–85900
cnl_rev_4TTT GCC CGA TAC AAT CTG AAA G85–106900
cnl_Pb_2 VIC (MGB)ATA AAA CCG GTG CCG CC38–22250
csw/synGF857TAT TTA TGG AAG GCA TGG TGT ATG935–958600Wang, X, 2011
R964TTG CCA TTC CAG AAA TAT CAC C1063–1042600
Pb907i FAM (BHQ)AAA TAT GGA GCG AAT GAT TAC AGT AAC TAT AAT GAA985–1020200
csaB/sacBF2531AAA ATT CAA TGG GTA TAT CAC GAA GA934–959900Mothershed, EA, 2004
R2624ATA TGG TGC AAG CTG GTT TCA ATA G1025–1001900
Pb2591i HEX (BHQ)CTA AAA GTA GGA AGG GCA CTT TGT GGC ATA AT992–961250
csxB/xcbBF173TGT CCC CAA CCG TTT ATT GG429–448900Mothershed, EA, 2004
R237TGC TGC TAT CAT AGC CGC C493–475900
Pb196 CY5 (BHQ)TGT TTG CCC ACA TGA ATG GCG G452–473250
csb/synDF737GCT ACC CCA TTT CAG ATG ATT TGT737–760900Wang, X, 2011
R882ACC AGC CGA GGG TTT ATT TCT AC905–883900
Pb839i CY5 (BHQ)AAG AGA TGG GYA ACA ACT ATG TAA TGT CTT TAT TT839–873250
csc/synEF478CCC TGA GTA TGC GAA AAA AAT T591–612600Mothershed, EA, 2004
R551TGC TAA TCC CGC CTG AAT G664–646600
Pb495i FAM (BHQ)TTT CAA TGC TAA TGA ATA CCA CCG TTT TTT TGC612–644200
csy/synFF787TCC GAG CAG GAA ATT TAT GAG AAT AC865–890900Wang, X, 2011
R929TTG CTA AAA TCA TTC GCT CCA TAT1010–987900
Pb1099i HEX (BHQ)TAT GGT GTA CGA TAT CCC TAT CCT TGC CTA TAA T948–981250
cseE/cap29eFcseE-2_Fwd1GAGGCTGGCAATGACCAATT470–488600Present study
cseE-2_Rev1CCCAGCATATCGACAACCAA548–529600
cseE-2_Pb1 FAM (MGB)ATCTTATGTGAACGTGGCGC490–509200
cszC/capZDcszC-1_Fwd1CAG GCC GAA GAG CGT TAT CA895–914900Present study
cszC-1_Rev1CGC CAT TCA GGG CGA TT950–934900
cszC-1_Pb1 NED (MGB)ACA GCT CTG GCC TTA G916–931250
cshCcshC-1_Fwd1AAG CCC GTT CCA AGA TCA TG1491–1510600Present study
cshC-1_Rev1GCG GTT TGG AGA AAT AAT ATG TGT T1563–1539600
cshC-1_Pb1 VIC (MGB)AAT GTC AGC CGT AAC TT1513–1529200

Sequences, positions and concentrations of primers and probes used in the 4 multiplexes, MGB: Minor Groove Binding/ BHQ: Black Whole Quencher, are two different types of Quencher. The probes obtained from CDC had a BHQ while the ones designed for this study the MGB quencher. In bold are base pairs that showed a mismatch with at least one of the alleles present in pubMLST, but not with the majority of them.

Sequences, positions and concentrations of primers and probes used in the 4 multiplexes, MGB: Minor Groove Binding/ BHQ: Black Whole Quencher, are two different types of Quencher. The probes obtained from CDC had a BHQ while the ones designed for this study the MGB quencher. In bold are base pairs that showed a mismatch with at least one of the alleles present in pubMLST, but not with the majority of them.

Study design and statistical analyses

Initially, 16 positive controls, representing all target genogroups (A, B, C, W, X, Y, H, E, Z, cnl), were used for the optimization of both gel-based and qPCR in monoplex and appropriate multiplexes. Optimal qualitative results from monoplex and multiplex assays were evaluated for gel-based PCR by visualizing the quality and strength of the bands, whereas optimal conditions were defined for the qPCR assay using quantitative Ct values. Then, 44 Malian isolates were analysed using all primers and probes in monoplex and multiplex assays in parallel to further evaluate the optimized PCR conditions for multiplex assays and ensure the multiplex assays were comparable to monoplex assays. Later, as more samples were prospectively characterized at Oxford University from other MenAfriCar countries, samples from Chad, Ethiopia, Ghana, Niger and Senegal were tested with the optimized multiplex assays (Fig 1). Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) (see definitions in Table 3) were calculated for primers/probe triplets (forward primer, reverse primer and probe for each qPCR) using the results obtained from Oxford University as a gold standard.
Fig 1

Summary of the methodology employed in the study and samples tested.

Table 3

Definition of sensitivity, specificity, positive predictive value and negative predictive value.

Carriage of meningococci (confirmed by the gold standard in Oxford):
PCR outcome/carriageCarriage presentNo carriage
PositiveTrue Positive (TP)False Positive (FP)
NegativeFalse Negative (FN)True Negative (TN)

Sensitivity (SS): Proportion of samples positive by the gold standard technique (true carriers) that were positive by PCR. Sensitivity = TP/(TP+FN)

Specificity (SP): Proportion of samples negative by the gold standard technique (true non-carriers) that were negative by PCR. Specificity = TN/(TN+FP)

Positive Predictive Value (PPV): Probability to have a positive result with the new PCR when it is positive with the gold standard (carriage of meningococci or carriage of the tested strain). PPV = TP/(TP+FP)

Negative Predictive Value (NPV): Probability to have a negative result with the new PCR when it is negative with the gold standard (no meningococcal carriage or carriage of the tested strain). NPV = TN/(TN+FN)

Sensitivity (SS): Proportion of samples positive by the gold standard technique (true carriers) that were positive by PCR. Sensitivity = TP/(TP+FN) Specificity (SP): Proportion of samples negative by the gold standard technique (true non-carriers) that were negative by PCR. Specificity = TN/(TN+FP) Positive Predictive Value (PPV): Probability to have a positive result with the new PCR when it is positive with the gold standard (carriage of meningococci or carriage of the tested strain). PPV = TP/(TP+FP) Negative Predictive Value (NPV): Probability to have a negative result with the new PCR when it is negative with the gold standard (no meningococcal carriage or carriage of the tested strain). NPV = TN/(TN+FN)

Results

Literature search and evaluation of primers and probes

Eleven papers describing 112 primers and 16 probes for gel-based or qPCR methods to detect and characterize meningococci were identified (S1 Table). Only papers that described the primer and probe sequences were used. Gel-based PCR assays targeting different genes were identified for N. meningitidis detection: 1 assay for crgA, 2 for porA, 2 for ctrA and 1 for sodC. Similarly, qPCR assays for characterization of genogroups were analyzed: 3 for A, 3 for W, 7 for X, 5 for B, 4 for C, 3 for Y, 1 for H, 2 for E, and 1 for Z. For the gel-based PCR assays: the same primers were often chosen for detection and genogrouping in different papers. The most frequent were for characterization of genogroups A, W, Y, B, C [22], and X [33]. For the qPCR assays: primers/probe triplets (forward primer, reverse primer and probe) were retrieved for porA (1 triplet), ctrA (2 triplets), and sodC (1 triplet) for the detection of N. meningitidis and for genogroups A (1 triplet), W (2 triplets), X (1 triplet), B (3 triplets), C (3 triplets), Y (2 triplets). In one of the most recent comprehensive assays, two multiplex PCR for genogroups A, W, X and B, C, Y were used successively [23]. Nineteen (14 primers and 5 probes–see Tables 1 and 2) out of the 68 primers and probes sequences evaluated within the PubMLST database had 1 to 3 mismatches, compared with the consensus sequences, which was considered acceptable. The Tm and dimer analyses generally gave acceptable results for gel-based and qPCR, except for H and Z that had to be redesigned to fit the cycling conditions in the gel-based PCR assay (Tables A, B, C, D, E, F, G and H in S2 Table). A final list of 47 primers and 12 probes was evaluated for our detection and characterization of the PCR algorithm (Tables 1 and 2). Primers and probes regions are represented schematically on their respective loci in Panels A, B, C and D in S1 Fig.

Optimisation of the four multiplex assays (1- porA, sodC, cnl; 2- A, W, X; 3- Y, B, C; 4- H, E, Z)

Sixteen positive controls from different genogroups were used to optimize both the gel-based and the real-time PCR assays. For gel-based assay, the optimal MgCl2 concentration for the assay was determined to be 10.4mM and this concentration was retained for the remaining experiments. Each reaction consisted of a 30μl solution with 0.5μl of each primer, 4μl of rlMMx (monoplex) or 6μl of rlMMx (multiplex) and molecular biology grade water (ddH2O). Table 2 presents the optimal concentrations for the selected primers and probes for real-time PCR (qPCR). The qPCR reaction consisted of a 25μl solution with 12.5 μl of 2X Gene Expression Master Mix and ddH2O.

Evaluation of sensitivity, specificity, PPV and NPV compared with our gold standard (S3 Table)

Gel-based assay (Table A in : Sixteen positive controls and the samples from Mali (n = 44) were used to compare monoplex and multiplex PCR. All meningococci identified at the University of Oxford were correctly detected and characterized by monoplex gel-based PCR resulting in a sensitivity of 100% for all genes except 75% for genogroup Y (see S3 Table). The porA and sodC sensitivities were decreased to 82.14% and 96.43% respectively when working in multiplex whereas it was 100% for cnl and all genogroups. The specificity of porA assay increased from 77.78% in monoplex to 88.89% in multiplex, whereas specificity of sodC decreased from 29.64% in monoplex to 25.93% in multiplex. Specificity was 100% for cnl and all genogroups except X and Z with 96.55% and 96.30% respectively in monoplex and 100% for cnl and all genogroups except X and B with 96.55% and 96.15% respectively in multiplex (Supplemental Table 3). Real-time PCR assay (Table B in : Starting with 100ng of DNA, eight 2-fold serial dilutions were performed to determine the Ct limit for categorizing a sample as positive. The last dilution, at a concentration of 0.79ng, systematically had a Ct lower or equal to 30. This is roughly equivalent to 40,000 genome copies which is far lower than the expected number of colony forming units after culture. The Ct limit was determined to be 30 cycles for crude DNA isolates. For this assay, a sample with a Ct lower or equal to 30 was considered positive and samples above 30 were considered negative (Fig 2).
Fig 2

qPCR standard curves.

Eight two-fold dilutions of DNA from each positive control were performed and tested in a qPCR assay with appropriate primers and probes. The Ct observed for each dilution is plotted against the DNA concentration demonstrating a decrease in Ct with increased DNA concentration and detection for all genogroups with a threshold of 30. sodC was empirically tested later and demonstrated the same threshold (data not shown).

qPCR standard curves.

Eight two-fold dilutions of DNA from each positive control were performed and tested in a qPCR assay with appropriate primers and probes. The Ct observed for each dilution is plotted against the DNA concentration demonstrating a decrease in Ct with increased DNA concentration and detection for all genogroups with a threshold of 30. sodC was empirically tested later and demonstrated the same threshold (data not shown). The sensitivity was 100% for all PCR assays evaluated in this study both in monoplex and multiplex. Specificity was poor for sodC with 25.93% in monoplex and 29.63% in multiplex. Specificity for porA was slightly decreased from 81.48% to 74.07% in multiplex. All cnl and genogroups had a specificity of 100% both in monoplex and multiplex except genogroup X with 96.55% in monoplex. No statistical differences were observed between the new MGB sodC probe and the original BHQ sodC probe; however, the new MGB probe detected N. meningitidis at lower Ct values (data not shown) and was included in the final assay.

Evaluation of the optimized multiplex assay using the pool of African carriage isolates (Table 4)

The best performing assay was tested in multiplex on 203 isolates from five other countries of the MenAfriCar study with the gel-based and qPCR assays making a total of 247 samples. Again, the comparison was made with the gold standard results from Oxford: for the detection by gel-based PCR assay, the best sensitivity was obtained with sodC (80.92%—with a specificity of 69.47%) and the best specificity with porA (93.68% with a sensitivity of 70.39%). Sensitivity for cnl and all genogroups ranged from 66.67% (genogroup X) to 100% for genogroup B and E, whereas specificity ranged from 97.99% (genogroup X) and 100% (genogroups C, Y, H and Z). For the qPCR assay, the best sensitivity and specificity was obtained with porA (96.05% and 91.58% respectively) showing no advantage of using sodC (94.74% and 77.89% respectively). For cnl and all genogroups, sensitivity ranged between 90% (genogroup A and Y) and 100%, whereas specificity ranged between 99.33% (genogroup X) and 100% (Table 4).
Table 4

Statistical analysis results for the multiplex gel-based and qPCR assays.

Gel-based
multiplex
SSSS 95% CISPSP 95% CIPPVPPV 95% CINPVNPV 95% CI
porA70.462.4, 77.593.786.8, 97.694.788.8, 98.066.457.8, 74.3
sodC80.973.7, 86.869.559.2, 78.580.973.8, 86.869.559.2, 78.5
Cnl85.575.6, 92.598.792.9, 10098.591.8, 10087.278.3, 93.4
A75.050.9, 91.399.295.9, 10093.869.8, 99.896.391.6, 98.8
W81.561.9, 93.798.494.3. 99.891.773.0, 99.096.191.1, 98.7
X66.79.4, 99.198.094.2, 99.640.05.3, 85.399.396.3, 100
B100.029.2, 10099.396.3, 10075.019.4, 99.4100.097.5, 100
C80.028.3, 99.5100.097.5, 100100.039.8, 10099.396.3, 100
Y80.044.4, 97.5100.097.4, 100100.063.1, 10098.695.1, 99.8
HNANA100.097.6, 100NANA100.097.6, 100
E100.02.5, 10099.396.3, 10050.01.3, 98.7100.097.6, 100
ZNANA100.097.6, 100NANA100.097.6, 100
porA/sodC88.882.7, 93.367.457.0, 76.681.374.6, 86.979.068.5, 87.3
Real-time
multiplex
SSSS 95% CISPSP 95% CIPPVPPV 95% CINPVNPV 95% CI
porA96.191.6, 98.591.684.1, 96.394.890.0, 97.793.586.5, 97.6
sodC94.789.9, 97.777.968.2, 85.887.381.2, 91.990.281.7, 95.7
Cnl94.787.1, 98.5100.095.3, 100100.095.0, 10095.087.7, 98.6
A90.068.3, 98.8100.097.2, 100100.081.5, 10098.594.7, 99.8
W92.675.7, 99.1100.097.1, 100100.086.3, 10098.494.4, 99.8
X100.029.2, 10099.396.3, 10075.019.4, 99.4100.097.5, 100
B100.029.2, 100100.097.5, 100100.029.2, 100100.097.6, 100
C100.047.8, 100100.097.5, 100100.047.8, 100100.097.5, 100
Y90.055.5, 99.7100.097.4, 100100.066.4, 10099.396.2, 100
HNANA100.097.6, 100NANA100.097.6, 100
E100.02.5, 10099.396.4, 10050.01.3, 98.7100.097.6, 100
ZNANA100.097.6, 100NANA100.097.6, 100
porA/sodC96.191.6, 98.577.968.2, 85.887.481.4, 92.092.584.4, 97.2

Results of both PCR assays tested only in multiplex on a panel of 247 samples from Chad, Ethiopia, Ghana, Mali, Niger and Senegal. Sensitivity, Specificity, PPV and NPV were assessed for each primers pair and primers/probe in the multiplex assays and presented as percentages (%) with 95% confidence intervals (CI).

Results of both PCR assays tested only in multiplex on a panel of 247 samples from Chad, Ethiopia, Ghana, Mali, Niger and Senegal. Sensitivity, Specificity, PPV and NPV were assessed for each primers pair and primers/probe in the multiplex assays and presented as percentages (%) with 95% confidence intervals (CI). The benefit of evaluating results from sodC and porA together, instead of individually from the same multiplex, was analysed by comparing each primers/probe sets taken individually or together. Sensitivity and NPV were improved by using both genes together and considering positive any samples that were positive for at least one of the targets for the gel-based PCR assay in comparison with porA or sodC alone from the same multiplex whereas the specificity and PPV were decreased. For the qPCR assay all statistical results for sodC were lower or equal to those for porA. Inclusion of sodC did not provide additional value (Table 4). From the panel of 247 samples from all six different countries, 152 were characterized as N. meningitidis at the University of Oxford using rplF sequencing [29]. Of these, 88.82% (135) isolates were correctly identified as meningococci by the gel-based PCR assay and 96.05% (146) by the qPCR assay. All genogroups, but H and Z, were identified in the panel tested: the most commonly represented was the cnl with 43.9%/48.4% (gel based/qPCR). Some genogroups considered as rare in the region were detected, such as B (2%) and E (0.66%) by both assays.

Discussion

Conventional bacteriological methods that are usually routinely used to detect and characterize meningococci are complex, long and involve several overnight cultures and chemical tests which might generate error [15]. Developing a simple and rapid PCR algorithm that detects and characterizes carriage of meningococci is important, especially in the meningitis belt where recent vaccinations with conjugate vaccines were carried out and carriage is usually low [14]. Therefore, it is important to correctly detect N. meningitidis in a context where transmission is high especially in young children and where the period of carriage is short [34]. In this study, after an in silico evaluation of the existing primers and probes, we evaluated a multiplex PCR algorithm by comparison with techniques that were validated and published in a reference laboratory at the University of Oxford (24, 30). Our multiplex PCR algorithm was later used for a meningococcal carriage study in The Gambia and improved the detection of carried meningococci by more than twice (239%) [35].To our knowledge, this is the first time that such an extensive evaluation was made for a carriage study in the meningitis belt, using the most advanced tools and following recommended advanced guidelines for qualitative techniques [32]. To optimise the sensitivity of our algorithm for the detection of meningococci, we targeted both porA and sodC genes simultaneously. The published sodC gel-based PCR primers were re-designed due to too many mismatches against the consensus sequence [18]. Similarly, primers and probe of qPCR targeting porA available from the literature [17] yielded too many mismatches and were re-designed entirely. Designing qPCR primers and probes for cnl identification was not an easy task as the cnl sequence is short and variable, but the design of two complementary forward primers (Table 2), allowed the complete coverage of the cnl sequences that were present in pubMLST at that time. Recent comparison of primers/probes sequences used in this study with a larger number of sequences now available in the pubMLST identified additional point mutations in newly published alleles (data not shown). Although most alleles are still covered by the primers and probes developed here, new variations within these primers/probes sequences may lead to decreased sensitivity and we advise a complete new in silico evaluation of primers and probes before using these. Since pubMLST is exponentially growing, we recommend our methodology to be applied–or, at a minimum, blasting of primers and probes to make them more robust–when developing or implementing new molecular diagnosis tools for N. meningitidis as well as other pathogens. The variability of the targeted genes between meningococcal strains might explain the sensitivity and specificity variations observed between monoplex and multiplex assays and future studies will be needed to investigate this further for the detection of N. meningitidis. A major strength of the developed algorithm is that the first multiplex assay (porA, sodC and cnl) allows the simultaneous detection of meningococci and the presence/absence of their capsule locus. Since cnl genotype is most common among meningococcal strains in carriage [11, 14], this assay improves the rapidity of N. meningitidis characterization. The sequential use of the following three multiplex assays for genogroup characterization, from the most frequent groups (A, W, and X followed by B, C, and Y) to the carriage uncommon genogroups (E, H and Z) in the meningitis belt, further reduces the time required for meningococcal characterization. The primers/probe sequences used for these genogroup assays could also be modified to fit the variable epidemiology of meningococci by region and over time. In this study, we have developed an algorithm that: (i) has a high sensitivity for the detection of meningococci; and, (ii) allows rapid characterization of all genogroups with high specificity. A strength of gel-based assays is that the assays joined two commonly used genes to detect N. meningitidis: porA and sodC in multiplex, which improved the sensitivity from 70.39% for porA and 80.92% for sodC alone to 88.82% (see Table 4) for meningococcal detection. However, no improvement in sensitivity and specificity was observed when adding sodC in the multiplex qPCR assay and we advise using only porA/cnl for the qPCR. This might be due to the modification of the published sodC probe to accommodate a MGB quencher in order to harmonize the quenchers in the first multiplex (porA, sodC, cnl). Indeed, “BHQ” probes are difficult to obtain from oligonucleotide suppliers, because of their unusual design [23]. A subsequent comparison of 44 Malian samples tested with both BHQ and MGB probes showed no differences in detection of isolates. However, the efficacy of the shortened MGB sodC probe should be further investigated. For genogroup characterization, multiplex qPCR that has already been evaluated were validated in gel-based PCR platform. The statistical results varied from one genogroup to the other (Table 4). For the two multiplexes (A, W, and X; B, C, and Y), published primers/probes were used and their statistical results were acceptable for all genogroups. The genogroup X primers set had the lowest sensitivity and PPV in the gel-based assay and may require redesign. Overall, the qPCR assay yielded better results than the gel-based PCR and should be the preferred assay for genogroup characterization. Our study used the laboratory results obtained from Oxford University as reference standard for the statistical analysis. The sensitivity, specificity, PPV and NPV may be affected by the transport conditions when DNA samples were shipped from MenAfriCar countries and how the samples were processed at Oxford University. This may have affected our comparisons between PCR tests realized in Bamako and analyses in Oxford. In addition, no qPCR assay for the rare genogroups H, E, and Z was available in Oxford, making the direct comparison difficult. The results generated in this study were compared to the ctrA sequencing results when available and may explain some of the observed discrepancies; indeed, the comparison of two different techniques could explain the low PPV for group E in both assays. The quality of the template may have also affected the detection of meningococci as most studies use DNA purified by kits. Boiled cell suspensions were purposely used to make our assays as inexpensive as possible and the good statistics obtained with those crude samples demonstrate the efficacy of the assays. Stringent rules were applied to determine whether a test was positive or not: by qPCR, a CT threshold of 30 was chosen based on preliminary results obtained (Fig 2), whereas the CDC/WHO reference guidelines recommend a threshold of 35 which, with the reagents and conditions used in our study, would have led to a considerable number of false positives. In conclusion, this algorithm allows the detection of N. meningitidis with high sensitivity for samples from 6 different countries of the meningitis belt, it significantly reduces the number of tests required for meningococcal detection and allows very specific characterization of samples for carriage studies in comparison with conventional bacteriological techniques.

Primers and probes positioned on appropriate genes.

Gel-based (green arrows) and rt (black arrows) PCR primers and probes for each multiplex (A-multiplex 1, B-multiplex 2, C-multiplex 3 and D-multiplex 4); the gene arrow pointing toward the 3’ end of the gene. Both forward primers (available in the literature and newly designed) for porA are shown on the gene (A). Figure adapted from Harisson OB and al. 2013. (PDF) Click here for additional data file.

List of papers that were selected for further analyses.

(XLSX) Click here for additional data file.

Primer and probe sequences general technical analysis.

Results of the BLAST analyses performed for each primer and probe using the NCBI BLAST tool. All BLAST results shown were done in the nucleotide collection database, against N. meningitidis (taxon id 487). The Tm and possible dimers were obtained using the primer express design tool. (XLSX) Click here for additional data file. A. Statistical results for gel-based PCR assay. Statistical analysis results of the gel-based PCR assay. Sensitivity, Specificity, Positive Predictive Value (PPV) and Negative Predictive Value (NPV) were assessed for each primers pair in the multiplex and monoplex assay pooling results from test on positive controls (n = 16) and the Malian samples (n = 44) and presented as percentages (%). B. Statistical results for the qPCR assay. Statistical analysis results of the qPCR assay. Sensitivity, Specificity, Positive Predictive Value (PPV) and Negative Predictive Value (NPV) were assessed for each primers pair in the multiplex and monoplex assay pooling results from test on positive controls (n = 16) and the Malian samples (n = 44) and presented as percentages (%). (DOCX) Click here for additional data file.

Database used for the analyses for the Chadian Site.

(XLSX) Click here for additional data file.

Database used for the analyses for the Ethiopian Site.

(XLSX) Click here for additional data file.

Database used for the analyses for the Ghanaian Site.

(XLSX) Click here for additional data file.

Database used for the analyses for the Malian Site.

(XLSX) Click here for additional data file.

Database used for the analyses for the Niger Site.

(XLSX) Click here for additional data file.

Database used for the analyses for the Senegalese Site.

(XLSX) Click here for additional data file.
  31 in total

1.  The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments.

Authors:  Stephen A Bustin; Vladimir Benes; Jeremy A Garson; Jan Hellemans; Jim Huggett; Mikael Kubista; Reinhold Mueller; Tania Nolan; Michael W Pfaffl; Gregory L Shipley; Jo Vandesompele; Carl T Wittwer
Journal:  Clin Chem       Date:  2009-02-26       Impact factor: 8.327

2.  Baseline meningococcal carriage in Burkina Faso before the introduction of a meningococcal serogroup A conjugate vaccine.

Authors:  Paul A Kristiansen; Fabien Diomandé; Stanley C Wei; Rasmata Ouédraogo; Lassana Sangaré; Idrissa Sanou; Denis Kandolo; Pascal Kaboré; Thomas A Clark; Abdoul-Salam Ouédraogo; Ki Ba Absatou; Charles D Ouédraogo; Musa Hassan-King; Jennifer Dolan Thomas; Cynthia Hatcher; Mamoudou Djingarey; Nancy Messonnier; Marie-Pierre Préziosi; Marc LaForce; Dominique A Caugant
Journal:  Clin Vaccine Immunol       Date:  2011-01-12

3.  The carrier state: Neisseria meningitidis.

Authors:  C V Broome
Journal:  J Antimicrob Chemother       Date:  1986-07       Impact factor: 5.790

4.  [Comparative epidemiologic study of meningococcic cerebrospinal meningitis in temperate regions and in the meningitis belt in Africa. Attempt at synthesis].

Authors:  L Lapeyssonnie
Journal:  Med Trop (Mars)       Date:  1968 Nov-Dec

Review 5.  An epidemiological review of changes in meningococcal biology during the last 100 years.

Authors:  Anne Abio; Keith R Neal; Charles R Beck
Journal:  Pathog Glob Health       Date:  2013-12-19       Impact factor: 2.894

6.  A novel porA-based real-time PCR for detection of meningococcal carriage.

Authors:  J Zoe Jordens; John E Heckels
Journal:  J Med Microbiol       Date:  2005-05       Impact factor: 2.472

7.  Clinical validation of multiplex real-time PCR assays for detection of bacterial meningitis pathogens.

Authors:  Xin Wang; M Jordan Theodore; Raydel Mair; Elizabeth Trujillo-Lopez; Mignon du Plessis; Nicole Wolter; Andrew L Baughman; Cynthia Hatcher; Jeni Vuong; Lisa Lott; Anne von Gottberg; Claudio Sacchi; J Matthew McDonald; Nancy E Messonnier; Leonard W Mayer
Journal:  J Clin Microbiol       Date:  2011-12-14       Impact factor: 5.948

8.  The Diversity of Meningococcal Carriage Across the African Meningitis Belt and the Impact of Vaccination With a Group A Meningococcal Conjugate Vaccine.

Authors: 
Journal:  J Infect Dis       Date:  2015-04-09       Impact factor: 5.226

9.  Continuing effectiveness of serogroup A meningococcal conjugate vaccine, Chad, 2013.

Authors:  Kadidja Gamougam; Doumagoum M Daugla; Jacques Toralta; Cyriaque Ngadoua; Florence Fermon; Anne-Laure Page; Mamoudou H Djingarey; Dominique A Caugant; Olivier Manigart; Caroline L Trotter; James M Stuart; Brian M Greenwood
Journal:  Emerg Infect Dis       Date:  2015-01       Impact factor: 6.883

10.  Meningococcal carriage in the African meningitis belt.

Authors: 
Journal:  Trop Med Int Health       Date:  2013-05-18       Impact factor: 2.622

View more
  3 in total

1.  RNA markers for ultra-rapid molecular antimicrobial susceptibility testing in fluoroquinolone-treated Klebsiella pneumoniae.

Authors:  Xi Yang; Marjan M Hashemi; Nadya Andini; Michelle M Li; Shuzhen Kuang; Karen C Carroll; Tza-Huei Wang; Samuel Yang
Journal:  J Antimicrob Chemother       Date:  2020-07-01       Impact factor: 5.790

2.  A Novel Platform Using RNA Signatures To Accelerate Antimicrobial Susceptibility Testing in Neisseria gonorrhoeae.

Authors:  Marjan M Hashemi; Nikhil Ram-Mohan; Xi Yang; Nadya Andini; Nicholas R Gessner; Karen C Carroll; Tza-Huei Wang; Samuel Yang
Journal:  J Clin Microbiol       Date:  2020-11-18       Impact factor: 5.948

3.  Toward Establishing Integrated, Comprehensive, and Sustainable Meningitis Surveillance in Africa to Better Inform Vaccination Strategies.

Authors:  Brenda Anna Kwambana-Adams; Adam L Cohen; Lee Hampton; Aquino Albino Nhantumbo; Robert S Heyderman; Martin Antonio; Andre Bita; Jason Mathiu Mwenda
Journal:  J Infect Dis       Date:  2021-09-01       Impact factor: 5.226

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.